PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA. Elena.Beyzarov@pfizer.com.\', \'Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.\', \'Information Management Operations Center of Excellence, Global Product Development Pfizer Inc, Peapack, NJ, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40264-020-01035-x
?:doi
?:hasPublicationType
?:journal
  • Drug safety
is ?:pmid of
?:pmid
?:pmid
  • 33354753
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.447
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor\'s Perspective.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all